JEREMY GORAL: Open Payments
NPI 1659897635 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,534 in 67 payments from 24 companies in 2025. Trend: 2023 $672 · 2024 $2,866 · 2025 $1,534
Food & beverage: $1,534
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 4 | $241 |
| Novo Nordisk Inc | 16 | $240 |
| SANOFI-AVENTIS U.S. LLC | 5 | $157 |
| Ascendis Pharma Endocrinology Inc | 3 | $87 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Mannkind Corporation | 3 | $76 |
| Abbott Laboratories | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $73 |
| Dexcom, Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $56 |
Products named: OMNIPOD, TZIELD, Wegovy, Yorvipath, Rybelsus, AFREZZA, FREESTYLE LIBRE 3, Kerendia.
Industry payments across AZ — which companies pay providers there.
